SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-010021
Filing Date
2023-03-27
Accepted
2023-03-27 16:32:28
Documents
8
Effectiveness Date
2023-03-27

Document Format Files

Seq Description Document Type Size
1 S-8 2023_s-8.htm S-8 224804
2 EX-5.1 impl-ex5_1.htm EX-5 18049
3 PDF COURTESY COPY impl-ex5_1.pdf EX-5 82866
4 EX-23.1 impl-ex23_1.htm EX-23 635
5 EX-23.2 impl-ex23_2.htm EX-23 4366
6 EX-24.1 impl-ex24_1.htm EX-24 66530
7 EX-FILING FEES impl-exfiling_fees.htm EX-FILING FEES 36161
8 GRAPHIC img167417242_0.jpg GRAPHIC 8380
  Complete submission text file 0000950170-23-010021.txt   477646
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Filer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: S-8 | Act: 33 | File No.: 333-270870 | Film No.: 23764925
SIC: 2834 Pharmaceutical Preparations